CAPITOL BIOLOGICS
Who We Are
Since 2004, BioFactura has evolved from a small-scale development lab into a full-service CDMO, establishing Capitol Biologics as a new division that supports the R&D and early-phase clinical trial manufacturing needs of emerging biotech firms.
Our expertise span biologic protein/complex monoclonal antibody-based drug development, bioprocessing, analytical development, and GMP manufacturing, ensuring seamless product development from concept to clinical readiness.